FDAFDA · Food and drugs·Recall number D-0250-2026
Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.
Published January 14, 2026 · Recall initiated: December 18, 2025
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of particulate matter - Glass like particles.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Imprimis NJOF, LLC
- Distributor
- U.S Nationwide
- Lot
- Lot: 25APR001A, 25APR001B, Expires: 04/03/2026.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.